Benzinga | Aug 17, 2021 06:15AM EDT

FDA Approves Globus Medical's Consolidated Imaging System

* The FDA has approved Globus Medical Inc's (NYSE:GMED) Excelsius3D, an intelligent intraoperative 3-in-1 imaging system.

* The imaging platform consolidates 360o cone-beam CT, fluoroscopy, and high-resolution digital radiography into one unified solution, eliminating the need for multiple imaging systems during one procedure.

* The system offers omnidirectional wheels and the elimination of a separate viewing station.

* Globus Medical is ramping up production and preparing for commercial release in Q4 of 2021.

* Excelsius3D is a mobile X-ray system designed for 2D fluoroscopy, 2D digital radiography, and 3D imaging of adult and pediatric patients.

* Price Action: GMED shares closed 2.04% higher at $77.96 on Monday.

* Related content: Benzinga's Full FDA Calendar.